Garrett C. Moraski

2.2k citations

35 papers · 1.6k indexed · h-index 23

Co-authors: Marvin J. Miller Scott G. Franzblau Helena I. Boshoff Sang‐Hyun Cho Lowell D. Markley Philip A. Hipskind Ute Möllmann Tanya Parish
Topics: Tuberculosis Research and Epidemiology (22 papers)Cancer therapeutics and mechanisms (14 papers)Mycobacterium research and diagnosis (10 papers)
Cited by: Infectious Diseases Molecular Medicine Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Nature Communications
Partner nations: United States Singapore Germany

In The Last Decade

Garrett C. Moraski

34 papers receiving 1.6k citations

Peers

Countries citing papers authored by Garrett C. Moraski

Since Specialization

Citations

This map shows the geographic impact of Garrett C. Moraski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett C. Moraski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett C. Moraski more than expected).

Fields of papers citing papers by Garrett C. Moraski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett C. Moraski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett C. Moraski. The network helps show where Garrett C. Moraski may publish in the future.

Co-authorship network of co-authors of Garrett C. Moraski

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett C. Moraski. A scholar is included among the top collaborators of Garrett C. Moraski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett C. Moraski. Garrett C. Moraski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosis 2026 ·Journal of Medicinal Chemistry ·Samsher Singh,Pearly Shuyi Ng,Umayal Lakshmanan,(unknown),(unknown),Bei Shi Lee,Shi Hua Ang,(unknown),(unknown),Garrett C. Moraski,(unknown),Michael Berney,Gerhard Grüber,Kévin Pethe	0
2	GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876 2023 ·Microbiology Spectrum ·Priya Ragunathan,Pearly Shuyi Ng,Samsher Singh,Wee Han Poh,(unknown),Nitin Pal Kalia,Simon B. Larsson,Amaravadhi Harikishore,Stuart A. Rice,Philip W. Ingham,Volker Müller,Garrett C. Moraski,Marvin J. Miller,Thomas Dick,Kévin Pethe,Gerhard Grüber	6
3	Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties 2022 ·Bioorganic Chemistry ·Rui Liu,Kate Marshall,Rui Ma,(unknown),Gauri Shetye,Zhihao Liu,Sang‐Hyun Cho,Hyunyoung Jeong,Scott G. Franzblau,Garrett C. Moraski,Marvin J. Miller	5
4	Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds 2020 ·PLoS ONE ·Garrett C. Moraski,Nathalie Deboosère,Kate Marshall,(unknown),Alexandre Vandeputte,Courtney Hastings,Lisa K. Woolhiser,Anne J. Lenaerts,Priscille Brodin,Marvin J. Miller	33
5	PvdF of pyoverdin biosynthesis is a structurally unique N10-formyltetrahydrofolate-dependent formyltransferase 2019 ·Archives of Biochemistry and Biophysics ·(unknown),(unknown),Garrett C. Moraski,Carol A. Caperelli,Graham R. Moran,Audrey L. Lamb	7
6	Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc1:aa3 in Mycobacterium tuberculosis 2019 ·Scientific Reports ·Nitin Pal Kalia,Bei Shi Lee,(unknown),Garrett C. Moraski,Marvin J. Miller,Kévin Pethe	27
7	Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer 2018 ·Nature Communications ·Nicole Scherr,(unknown),Sangeeta Susan Thomas,Aurélie Chauffour,Nitin Pal Kalia,(unknown),Marie‐Thérèse Ruf,Araceli Lamelas,Malathy Sony Subramanian Manimekalai,Gerhard Grüber,Norihisa Ishii,Koichi Suzuki,Marcel Tanner,Garrett C. Moraski,Marvin J. Miller,Matthias Witschel,Vincent Jarlier,Gerd Pluschke,Kévin Pethe	52
8	Decarboxylation involving a ferryl, propionate, and a tyrosyl group in a radical relay yields heme b 2018 ·Journal of Biological Chemistry ·Bennett R. Streit,Arianna I. Celis,Garrett C. Moraski,Krista A. Shisler,Eric M. Shepard,Kenton R. Rodgers,Gudrun S. Lukat-Rodgers,Jennifer L. DuBois	22
9	Structure-Based Mechanism for Oxidative Decarboxylation Reactions Mediated by Amino Acids and Heme Propionates in Coproheme Decarboxylase (HemQ) 2016 ·Journal of the American Chemical Society ·Arianna I. Celis,George H. Gauss,Bennett R. Streit,Krista A. Shisler,Garrett C. Moraski,Kenton R. Rodgers,Gudrun S. Lukat-Rodgers,John W. Peters,Jennifer L. DuBois	42
10	Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates 2014 ·Bioorganic & Medicinal Chemistry Letters ·Garrett C. Moraski,Allen G. Oliver,Lowell D. Markley,Sang‐Hyun Cho,Scott G. Franzblau,Marvin J. Miller	42
11	Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model 2014 ·PLoS ONE ·Yong Cheng,Garrett C. Moraski,Jeffrey W. Cramer,Marvin J. Miller,Jeffrey S. Schorey	50
12	A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis 2013 ·PLoS ONE ·Juliane Ollinger,Mai A. Bailey,Garrett C. Moraski,Allen Casey,Stephanie K. Florio,Torey Alling,Marvin J. Miller,Tanya Parish	138
13	Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels−Alder reaction 2012 ·Bioorganic & Medicinal Chemistry ·Cheng Ji,(unknown),Garrett C. Moraski,Jane A. Thanassi,Michael J. Pucci,Scott G. Franzblau,Ute Möllmann,Marvin J. Miller	6
14	Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds 2012 ·Bioorganic & Medicinal Chemistry ·Garrett C. Moraski,Lowell D. Markley,Mayland Chang,Sang‐Hyun Cho,Scott G. Franzblau,(unknown),Helena I. Boshoff,Marvin J. Miller	90
15	Allylic thiocyanates as a new class of antitubercular agents 2012 ·Bioorganic & Medicinal Chemistry Letters ·Gustavo P. Silveira,(unknown),Luciano Fernandes,Garrett C. Moraski,Sang‐Hyun Cho,(unknown),Scott G. Franzblau,Marcus M. Sá	22
16	One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria 2011 ·The Journal of Antibiotics ·Garrett C. Moraski,Jane A. Thanassi,Steven D. Podos,Michael J. Pucci,Marvin J. Miller	11
17	Structure–activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters 2010 ·European Journal of Medicinal Chemistry ·Garrett C. Moraski,Mayland Chang,Adriel Villegas‐Estrada,Scott G. Franzblau,Ute Möllmann,Marvin J. Miller	108
18	Utilization of the Suzuki Coupling to Enhance the Antituberculosis Activity of Aryloxazoles 2010 ·Heterocycles ·Marvin J. Miller,Garrett C. Moraski,Scott G. Franzblau	13
19	Synthesis of Dideoxymycobactin Antigens Presented by CD1a Reveals T Cell Fine Specificity for Natural Lipopeptide Structures 2009 ·Journal of Biological Chemistry ·David C. Young,Anne Kasmar,Garrett C. Moraski,Tan‐Yun Cheng,Andrew J. Walz,Jingdan Hu,(unknown),Gregory W. Endres,(unknown),Dirk M. Zajonc,Catherine E. Costello,Marvin J. Miller,D. Branch Moody	22
20	Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents 2009 ·BioMetals ·Marvin J. Miller,Helen He Zhu,(unknown),Chunrui Wu,Andrew J. Walz,(unknown),(unknown),Garrett C. Moraski,Albert A. Minnick,(unknown),Jingdan Hu,(unknown),E. Kurt Dolence,Li Dong,Scott G. Franzblau,François Malouin,Ute Möllmann	77

About Garrett C. Moraski

Garrett C. Moraski is a scholar working on Infectious Diseases, Molecular Medicine and Organic Chemistry, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (22 papers), Cancer therapeutics and mechanisms (14 papers) and Mycobacterium research and diagnosis (10 papers). The work is most often cited by research in Infectious Diseases (597 citations), Molecular Medicine (152 citations) and Organic Chemistry (774 citations). Garrett C. Moraski has collaborated with scholars based in United States, Singapore and Germany. Frequent co-authors include Marvin J. Miller, Scott G. Franzblau, Helena I. Boshoff, Sang‐Hyun Cho, Lowell D. Markley, Philip A. Hipskind, Ute Möllmann, Tanya Parish, Patricia A. Miller and Mai A. Bailey. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact